The company formed as a joint project between Scorpion Medical and Monet Medical to provide medical technologies that are anticipated to enhance physicians’ use of orthobiologic materials and surgical procedures for treating orthopedic conditions.
Biologic Therapies plans to use autologous biologic therapy, or the body’s own stem cells, to increase healing potential and improve surgical and non-surgical results. The treatments apply to injuries involving the knee, ankle, elbow and shoulder as well as regeneration of cartilage and bone.
Related Articles on Orthopedic and Spine Devices:
K2M Hires 3 New International Team Leaders
11 Spine Devices Receive FDA 510(k) Clearance in September
15 Orthopedic and Spine Device Company Executive Moves
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
